Suchergebnisse - "Ferro, Antonella"

PubPharm (5)

1

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

enthalten in: Gynecologic oncology | 2019

von Daniele, G. | Arenare, L. | Scambia, G. | +25

2

Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer : the MITO-2 randomized phase III trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2011

von Pignata, S. | Scambia, G. | Ferrandina, G. | +27

3

Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer : preliminary results of the MITO-2 randomized trial

enthalten in: BMC cancer | 2006

von Pignata, S. | Scambia, G. | Savarese, A. | +18

4

Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial

enthalten in: BMC cancer | 2006

von Pignata, S. | Scambia, G. | Savarese, A. | +17

5

Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial

enthalten in: BMC cancer | 2006

von Pignata, S. | Scambia, G. | Savarese, A. | +17

1
[1]